{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:19:19Z","timestamp":1780514359568,"version":"3.54.1"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Pharm in Drug Dev"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pritelivir is a novel viral helicase\u2010primase inhibitor active against herpes simplex virus. In vitro drug\u2010drug interaction studies indicated that pritelivir has the potential for clinically relevant interactions on the cytochrome P450 (CYP) enzymes 2C8, 2C9, 3A4, and 2B6, and intestinal uptake transporter organic anion transporting polypeptide (OATP) 2B1 and efflux transporter breast cancer resistance protein (BCRP). This was evaluated in 2 clinical trials. In 1 trial the substrates flurbiprofen (CYP2C9), bupropion (CYP2B6), and midazolam (CYP3A4) were administered simultaneously as part of the Geneva cocktail, while the substrate celiprolol (OAPT2B1) was administered separately. In another trial, the substrates repaglinide (CYP2C8) and rosuvastatin (BCRP) were administered separately. Exposure parameters of the substrates and their metabolites (flurbiprofen and bupropion only) were compared after administration with or without pritelivir under therapeutic concentrations. The results of these trials indicated that pritelivir has no clinically relevant effect on the exposure of substrates for the intestinal uptake transporter OATP2B1 and the CYP enzymes 3A4, 2B6, 2C9, and 2C8, and has a weak inhibitory effect on the intestinal efflux transporter BCRP. In summary, the results suggest that pritelivir has a low drug\u2010drug interaction potential.<\/jats:p>","DOI":"10.1002\/cpdd.1408","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T10:39:32Z","timestamp":1715855972000},"page":"755-769","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the Clinical Drug\u2010Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach"],"prefix":"10.1002","volume":"13","author":[{"given":"Michiel","family":"de Vries","sequence":"first","affiliation":[{"name":"Molenpad ClinPharm Support  Weesp The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bonsmann","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Pausch","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"},{"name":"Present affiliation: BioNTech SE  Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Sumner","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Birkmann","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kropeit","sequence":"additional","affiliation":[{"name":"AiCuris Anti\u2010infective Cures AG  Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0402-392"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00668"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.13.192"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.08.024"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02641-14"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1766-1772.2002"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/095632020701800104"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301150"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.18189"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1241"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1358"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/09564624211006568"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01732-22"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac165"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.187"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.081927"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.723"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250802017715"},{"issue":"1","key":"e_1_2_8_20_1","first-page":"S94","article-title":"Comparing various in vitro prediction criteria to assess the potential of a new molecular entity (NME) to inhibit organic anion transporter 1 and 3 (OAT1 and 3)","volume":"99","author":"Dong Z","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"e_1_2_8_21_1","first-page":"S94","article-title":"Comparing various in vitro prediction criteria to assess the potential of a new molecular entity (NME) to inhibit OCT2 and MATE transporters in vivo","volume":"99","author":"Dong Z","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3028"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.045"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.086496"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.83"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12586"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1392"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0194"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2018.01.009"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13159"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010393342"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12672"}],"container-title":["Clinical Pharmacology in Drug Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpdd.1408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T01:40:37Z","timestamp":1720057237000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/cpdd.1408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/cpdd.1408"],"URL":"https:\/\/doi.org\/10.1002\/cpdd.1408","archive":["Portico"],"relation":{},"ISSN":["2160-763X","2160-7648"],"issn-type":[{"value":"2160-763X","type":"print"},{"value":"2160-7648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"2023-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}